Compounds, compositions and methods are provided for modulating the
expression of HIF1-beta. The compositions comprise oligonucleotides,
targeted to nucleic acid encoding HIF1-beta. Methods of using these
compounds for modulation of HIF1-beta expression and for diagnosis and
treatment of diseases and conditions associated with expression of
HIF1-beta are provided.